Epidemiological study to describe NSCLC clinical management patterns in Europe. Lung-EPICLIN - EPICLIN
Study identifier:NIS-OEU-DUM-2008/1
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Study Complete
Official Title
Epidemiological study to describe Non-small cell lung cancer (NSCLC) clinical management patterns in Europe. Lung
Medical condition
NSCLC
Phase
-
Healthy volunteers
No
Study drug
-
Sex
All
Actual Enrollment
3513
Study type
Observational
Age
18 Years +
Date
Study Start Date: 01 Jan 2009
Primary Completion Date: 01 Jul 2010
Study Completion Date: 01 Jul 2010
Study design
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verification:
Verified 01 Apr 2014 by AstraZeneca Pharmaceuticals
Sponsors
AstraZeneca Pharmaceuticals
Collaborators
-
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|---|
| 1 All NSCLC patients attending the responsible department of treating this type of patients (e.g. Oncology Department, Pneumology Department) for the first time (regardless of whether the patient is diagnosed with locally, advanced or metastatic disease) at the participating sites from the first of January 2009 to the end of March 2009. Patients diagnosed, or even treated, in other departments within the same hospital or in another hospital are susceptible to be included in the study if full access to the patient’s medical record is made available. | - |
Contacts
Investigators
Principal Investigator
Alfredo Carrato
Hospital Ramón y Cajal, Madrid (Spain)
